Tradestie Institutional Equity Comparison Engine
CWVX vs CRCA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRCA Overall Edge
CRCA Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares Ultra CRCL (CRCA) driven by superior Momentum & Technical. Fundamentally, CWVX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CRCA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CWVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CRCA sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CWVX N/M vs CRCA N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
CRCA
1Y -34.0% vs +60.9% ยท 52W Pos 2% vs 7%
Options & Structure Winner
Tie
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
CWVX
Cboe BZX
Tradr 2X Long CRWV Daily ETF
Institutional Equity
$3.95
-12.8% 1D
Market Cap
N/A
1M Return
-43.57%
1Y Return
-34.0%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 65.0
Fund 58.0
Flow 50.0
Mom 60.0
CRCA
NYSE Arca
ProShares Ultra CRCL
Institutional Equity
$7.83
-14.56% 1D
Market Cap
N/A
1M Return
-53.64%
1Y Return
+60.88%
Forward P/E
N/M
Unified AI Score
51.0 / 100
HOLD
Tech 53.0
Fund 54.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CWVX -34.0%
CRCA +60.88%
Spread: +94.88 pp (CRCA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CWVX TTM Op. Margin: N/A
CRCA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CWVX vs CRCA. Trailing 12-month operating profitability (CWVX N/A vs CRCA N/A) and valuation multiples (CWVX N/M vs CRCA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CWVX | CRCA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 2% ($3โ$57) | 7% ($1โ$93) | Stronger Trend | CRCA |
| Beta / 30D Volatility Risk Regime | 6.66ฮฒ ยท 271% Vol | 4.88ฮฒ ยท 137% Vol | Lower Realized Risk | CRCA |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 51.0 / 100 (HOLD) | Higher Composite | CWVX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CWVX vs CRCA Buy Guide
CWVX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
CRCA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CWVX nor CRCA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.